Prosecution Insights
Last updated: May 29, 2026

Fresenius Kabi Deutschland GmbH

9 pending office actions • 7 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days

Portfolio Summary

9
Total Pending OAs
7
Non-Final OAs
1
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

6
Overdue
1
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (6)Due ≤ 7 days (1)Due ≤ 30 days (1)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
7
Medium (78%)
0
Easy (0%)
2
Unknown (22%)

Rejection Statute Mix

BucketCases
§103 only6 (67%)
§102 only1 (11%)
No statute on record2 (22%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
33% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
6
Mechanical / Eng
67% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BARRY, DAPHNE MARIE 1 75.6% +29.9%
SMALLEY, JAMES N 1 70.3% -10.1%
LOCKARD, JON MCCLELLAND 1 74.5% +27.0%
OSINSKI, BRADLEY JAMES 1 78.5% +11.3%
FARRAR, LAUREN PENG 1 78.9% +15.2%
SCHMIDT, EMILY LOUISE 1 58.7% +36.4%
ARBLE, JESSICA R 1 65.6% +26.3%
CHEONG, CHEOM-GIL 1 65.0% +54.4%
KERSHAW, KELLY P 1 17.7% +16.8%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
16075294 High caloric, high protein nutritional formula comprising collagen KERSHAW, KELLY P 105d overdue

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17894455 DRUG CONTAINER OSINSKI, BRADLEY JAMES 127d overdue
16075294 High caloric, high protein nutritional formula comprising collagen KERSHAW, KELLY P 105d overdue
17759758 PISTON STOP FOR A MEDICAL SYRINGE AND MEDICAL SYRINGE WITH A PISTON STOP FARRAR, LAUREN PENG 60d overdue
17680155 LIQUID PHARMACEUTICAL COMPOSITION CHEONG, CHEOM-GIL 46d overdue
17759772 SYRINGE AND SYRINGE BODY SCHMIDT, EMILY LOUISE 44d overdue
17777823 Connector and Connection System for a Medical Packaging, and Method for Providing a Liquid for a Medical Packaging ARBLE, JESSICA R 7d
18494630 Liquid Pharmaceutical Composition Comprising an Anti-IL-6 Receptor Antibody LOCKARD, JON MCCLELLAND 21d
18981552 INSTALLATION FOR PRODUCING A MEDICAL PREPARATION BARRY, DAPHNE MARIE 34d

Top Art Units

Art UnitApps
3783 3
3753 1
3733 1
1647 1
3781 1
1645 1
1791 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18981552 INSTALLATION FOR PRODUCING A MEDICAL PREPARATION BARRY, DAPHNE MARIE 3753 §103 Non-Final OA 34d Pending Dec 15, 2024
18915096 SEALING CAP FOR A CONTAINER FOR HOLDING A MEDICAL LIQUID SMALLEY, JAMES N 3733 §103 Non-Final OA 45d overdue Pending Oct 14, 2024
18494630 Liquid Pharmaceutical Composition Comprising an Anti-IL-6 Receptor Antibody LOCKARD, JON MCCLELLAND 1647 Other Non-Final OA 21d Pending Oct 25, 2023
17894455 DRUG CONTAINER OSINSKI, BRADLEY JAMES 3783 §102 Final Rejection 127d overdue Pending Aug 24, 2022
17759758 PISTON STOP FOR A MEDICAL SYRINGE AND MEDICAL SYRINGE WITH A PISTON STOP FARRAR, LAUREN PENG 3783 §103 Non-Final OA 60d overdue Pending Jul 29, 2022
17759772 SYRINGE AND SYRINGE BODY SCHMIDT, EMILY LOUISE 3783 §103 Non-Final OA 44d overdue Pending Jul 29, 2022
17777823 Connector and Connection System for a Medical Packaging, and Method for Providing a Liquid for a Medical Packaging ARBLE, JESSICA R 3781 §103 Non-Final OA 7d Pending May 18, 2022
17680155 LIQUID PHARMACEUTICAL COMPOSITION CHEONG, CHEOM-GIL 1645 Other Non-Final OA 46d overdue Pending Feb 24, 2022
16075294 High caloric, high protein nutritional formula comprising collagen KERSHAW, KELLY P 1791 §103 Non-Final OA 105d overdue Pending Aug 03, 2018

Managing Fresenius Kabi Deutschland GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month